Denali Therapeutics Inc. (DNLI) quarterly income statement — complete revenue, gross profit & net income history
Denali Therapeutics Inc. (DNLI) annual income statement — 11-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 17.78M | 3.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.27M | 294.12M | 35.14M | 10.28M | 3.56M | 52.48M | 42.14M | 12.51M |
| Revenue Growth % | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | -64.4% | 460.45% | -16.61% | -17.83% | -32.66% | 128.78% | 431.88% | -96.05% |
| Cost of Goods Sold | 192K | 93K | 2.85M | 2.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 1.08% | 2.58% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 17.59M | 3.51M | -2.85M | -2.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.27M | 294.12M | 35.14M | 10.28M | 3.56M | 52.48M | 42.14M | 12.51M |
| Gross Margin % | 98.92% | 97.42% | - | - | - | - | - | - | - | - | - | - | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | -64.4% | 460.45% | -16.61% | -17.83% | -32.66% | 128.78% | 431.88% | -96.05% |
| Operating Expenses | 144.34M | 134.05M | 134.51M | 134.5M | 137.43M | 134.96M | 145.58M | 129.85M | 123.19M | 116.59M | 117.72M | 132.57M | 115.06M | 123.64M | 155.96M | 115.63M | 111.05M | 113.9M | 108.64M | 89.64M |
| OpEx % of Revenue | 811.89% | 3719.53% | - | - | - | - | - | - | - | - | - | - | 9081.45% | 42.04% | 443.8% | 1124.45% | 3120.12% | 217.03% | 257.8% | 716.28% |
| Selling, General & Admin | 37.48M | 36.28M | 30.67M | 36.59M | 35.48M | 32.27M | 29.35M | 30.06M | 24.95M | 25.19M | 25.24M | 24.77M | 25.32M | 26.12M | 27.14M | 23.52M | 23.26M | 21.16M | 22.54M | 21.76M |
| SG&A % of Revenue | 210.85% | 1006.74% | - | - | - | - | - | - | - | - | - | - | 1998.82% | 8.88% | 77.23% | 228.69% | 653.53% | 40.32% | 53.49% | 173.88% |
| Research & Development | 106.1M | 97.02M | 103.85M | 97.91M | 101.95M | 102.7M | 116.23M | 99.79M | 98.24M | 91.4M | 107.02M | 107.8M | 89.74M | 97.52M | 128.82M | 92.11M | 87.79M | 92.74M | 86.1M | 67.88M |
| R&D % of Revenue | 596.82% | 2691.98% | - | - | - | - | - | - | - | - | - | - | 7082.64% | 33.16% | 366.57% | 895.76% | 2466.59% | 176.71% | 204.31% | 542.4% |
| Other Operating Expenses | 750K | 750K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -126.75M | -130.54M | -137.36M | -137.37M | -137.43M | -134.96M | -145.58M | -129.85M | -123.19M | -116.59M | -117.72M | -132.57M | -113.8M | 170.48M | -120.81M | -105.34M | -107.49M | -61.42M | -66.5M | -77.12M |
| Operating Margin % | -712.97% | -3622.11% | - | - | - | - | - | - | - | - | - | - | -8981.45% | 57.96% | -343.8% | -1024.45% | -3020.12% | -117.03% | -157.8% | -616.28% |
| Operating Income Growth % | 7.77% | 3.28% | 5.65% | -5.79% | -11.57% | -15.76% | -23.67% | 2.06% | -8.25% | -168.39% | 2.57% | -25.85% | -5.87% | 377.59% | -81.68% | -36.6% | -25.58% | 0.65% | 6.63% | -131.6% |
| EBITDA | -123.18M | -127.89M | -134.51M | -133.58M | -133.57M | -131.88M | -142.37M | -127.23M | -120.92M | -114.65M | -115.55M | -130.4M | -111.58M | 172.77M | -110.77M | -101.25M | -105.34M | -59.34M | -64.42M | -75.03M |
| EBITDA Margin % | -692.86% | -3548.5% | - | - | - | - | - | - | - | - | - | - | -8806.47% | 58.74% | -315.21% | -984.66% | -2959.96% | -113.08% | -152.87% | -599.54% |
| EBITDA Growth % | 7.78% | 3.03% | 5.52% | -5% | -10.46% | -15.03% | -23.21% | 2.43% | -8.37% | -166.36% | -4.32% | -28.78% | -5.92% | 391.13% | -71.95% | -34.96% | -26.3% | 0.45% | 6.79% | -130.47% |
| D&A (Non-Cash Add-back) | 3.58M | 2.65M | 2.85M | 3.78M | 3.86M | 3.08M | 3.21M | 2.62M | 2.27M | 1.94M | 2.16M | 2.18M | 2.22M | 2.29M | 10.05M | 4.09M | 2.14M | 2.07M | 2.08M | 2.09M |
| EBIT | 70.13M | -127.55M | -128.45M | -128.45M | -126.9M | -124.12M | -132.97M | -114.69M | -107.19M | -99.03M | -132.25M | -132.57M | -113.8M | 170.48M | -120.81M | -105.34M | -107.49M | -61.42M | -66.5M | -77.12M |
| Net Interest Income | 0 | 0 | 8.91M | 8.92M | 10.53M | 10.84M | 12.61M | 15.16M | 15.99M | 17.57M | 15.91M | 13.13M | 14.44M | 12.9M | 11.03M | 6.66M | 4.19M | 2.65M | 1.28M | 1.28M |
| Interest Income | 0 | 0 | 8.91M | 8.92M | 10.53M | 10.84M | 12.61M | 15.16M | 15.99M | 17.57M | 15.91M | 13.13M | 14.44M | 12.9M | 11.03M | 6.66M | 4.19M | 2.65M | 1.28M | 1.28M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 196.88M | 2.99M | 8.91M | 8.92M | 10.53M | 10.84M | 12.61M | 15.16M | 15.99M | 17.57M | 15.91M | 13.13M | 14.44M | 12.9M | 11.03M | 6.66M | 4.19M | 2.65M | 1.28M | 1.28M |
| Pretax Income | 70.13M | -127.55M | -128.45M | -128.45M | -126.9M | -124.12M | -132.97M | -114.69M | -107.19M | -99.03M | -101.8M | -119.44M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.77M | -65.22M | -75.84M |
| Pretax Margin % | 394.45% | -3539.21% | - | - | - | - | - | - | - | - | - | - | -7841.59% | 62.35% | -312.4% | -959.68% | -2902.47% | -111.98% | -154.77% | -606.01% |
| Income Tax | 0 | 0 | 0 | 102K | 0 | 0 | 0 | 68K | 0 | 0 | 0 | 30K | 0 | 0 | 0 | -6K | 0 | 27K | 0 | -575K |
| Effective Tax Rate % | 0% | 0% | 0% | -0.08% | 0% | 0% | 0% | -0.06% | 0% | 0% | 0% | -0.03% | 0% | 0% | 0% | 0.01% | 0% | -0.05% | 0% | 0.76% |
| Net Income | 70.13M | -127.55M | -128.45M | -128.55M | -126.9M | -124.12M | -132.97M | -114.75M | -107.19M | -99.03M | -101.8M | -119.47M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.79M | -65.22M | -75.26M |
| Net Margin % | 394.45% | -3539.21% | - | - | - | - | - | - | - | - | - | - | -7841.59% | 62.35% | -312.4% | -959.62% | -2902.47% | -112.03% | -154.77% | -601.41% |
| Net Income Growth % | 155.26% | -2.77% | 3.4% | -12.02% | -18.39% | -25.34% | -30.62% | 3.95% | -7.89% | -154% | 7.27% | -21.07% | 3.82% | 411.91% | -68.32% | -31.11% | -22.12% | 3.13% | 6.88% | -130.73% |
| Net Income (Continuing) | 70.13M | -127.55M | -128.45M | -128.55M | -126.9M | -124.12M | -132.97M | -114.75M | -107.19M | -99.03M | -101.8M | -119.47M | -99.35M | 183.38M | -109.78M | -98.68M | -103.3M | -58.79M | -65.22M | -75.26M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.37 | -0.68 | -0.69 | -0.73 | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 | -0.86 | -0.72 | 1.30 | -0.80 | -0.74 | -0.84 | -0.48 | -0.52 | -0.62 |
| EPS Growth % | 150% | 5.56% | 11.54% | -8.96% | -17.46% | -22.03% | -14.71% | 22.09% | 12.5% | -145.38% | 15% | -16.22% | 14.29% | 370.83% | -53.85% | -19.35% | -21.74% | 2.04% | 10.34% | -132.46% |
| EPS (Basic) | 0.37 | -0.68 | -0.69 | -0.73 | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 | -0.59 | -0.68 | -0.86 | -0.72 | 1.34 | -0.80 | -0.74 | -0.84 | -0.48 | -0.52 | -0.62 |
| Diluted Shares Outstanding | 192.08M | 187.31M | 186.64M | 175.46M | 172.42M | 171.45M | 171.22M | 170.09M | 169.46M | 168.83M | 149.4M | 138.25M | 137.64M | 140.93M | 136.52M | 132.88M | 123.47M | 123.01M | 122.67M | 122.16M |
| Basic Shares Outstanding | 188.39M | 187.31M | 186.64M | 175.46M | 172.42M | 171.45M | 171.22M | 170.09M | 169.46M | 168.83M | 149.4M | 138.25M | 137.64M | 137.05M | 136.52M | 132.88M | 123.47M | 122.49M | 122.67M | 122.16M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |